ArticleESMO real world data and digital oncology2026
Real-world survival benefit of adding durvalumab to chemotherapy in cholangiocarcinoma: a retrospective cohort analysis from a German Comprehensive Cancer Centre.
S Elbasan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.